EyePoint Pharmaceuticals ... (EYPT)
6.57
-0.14 (-2.09%)
At close: Apr 24, 2025, 3:59 PM
13F Institute Ownership
Total Institutes of 150 in EyePoint Pharmaceuticals expanded their positions with an increase of 6 investors compared to the previous quarter. An additional 15.93M shares, as total invested capital grew by $77.21M with ownership percentage increasing from 107.44% to 136.69%.
Options Activity
Institutions are holding Calls/Puts contracts nearly balanced, indicating a neutral sentiment.
Put/Call 1.200
1.20
Call Flow 187,300
45%
Put Flow 224,800
55%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 15.29% | 8.32M | +0.00% | 62.02M | 3.41% |
| Suvretta Capital Management, L... | 12.46% | 6.78M | +31.05% | 50.53M | 1.72% |
| Adage Capital Partners Gp, L.l... | 10.56% | 5.75M | +51.66% | 42.84M | 0.07% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.